Trials / Completed
CompletedNCT01634308
Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Clinical study was to evaluate the Efficacy and Safety of bongros-BMP compared to Bio-oss for Regeneration of alveolar bone tissue after Maxillary sinus floor augmentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Novosis(bongros/BMP-2) | |
| DRUG | Bio-oss |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2012-07-06
- Last updated
- 2012-07-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01634308. Inclusion in this directory is not an endorsement.